当前位置: X-MOL 学术Complement. Ther. Clin. Pract. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pharmacopuncture for stroke survivors: A systematic review of randomized controlled trials in South Korea.
Complementary Therapies in Clinical Practice ( IF 2.2 ) Pub Date : 2020-05-01 , DOI: 10.1016/j.ctcp.2020.101179
Mikyung Kim 1 , Chang-Ho Han 2
Affiliation  

Background and purpose

Pharmacopuncture is one of the widely used interventions for stroke in Korea, but there is a lack of such evidence. This study was aimed to summarize the currently available evidence on the use of pharmacopuncture for stroke in the clinical practice of Korean medicine.

Methods

A systematic review of randomized controlled trials (RCTs) to evaluate the efficacy and safety of pharmacopuncture for stroke in Korea was conducted.

Results

Pharmacopuncture using bee venom was significantly beneficial for improving motor function and relieving the post-stroke shoulder pain. No serious adverse events were reported. The overall risk of bias of the included studies indicated a certain degree of concern and the level of evidence was low.

Conclusion

The majority of RCTs have focused on the pain relief effects of bee venom injection. However, the quantity and quality of the evidence are not sufficiently high to draw definitive conclusions on this topic.



中文翻译:

中风幸存者的药物穿刺:韩国随机对照试验的系统评价。

背景和目的

药物穿刺是韩国广泛使用的中风干预措施之一,但缺乏此类证据。这项研究旨在总结在韩国医学的临床实践中使用药物疗法治疗中风的现有证据。

方法

对韩国进行的随机对照试验(RCT)进行系统评价,以评估药物治疗中风的有效性和安全性。

结果

使用蜂毒的药物穿刺对改善运动功能和减轻中风后肩痛具有明显的好处。没有严重不良反应的报道。纳入研究的总体偏倚风险表明存在一定程度的关注,证据水平低。

结论

大多数RCT都集中在蜂毒注射液的止痛作用上。但是,证据的数量和质量不够高,不足以得出关于该主题的明确结论。

更新日期:2020-05-01
down
wechat
bug